Stockchase Opinions

Daniel Lloyd Cascades Inc CAS-T BUY Nov 24, 2017

Had a big miss last quarter, largely on the back of their tissue exposure, so this is a pretty opportune time to be buying. The free cash flow is in the neighbourhood of 15%. If there was an upswing in the tissue space, this would benefit, but is not something he is holding his breath for.

$12.590

Stock price when the opinion was issued

east coast forestry
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY
Believes company is preforming well in tough market. Company pairing down operations and cleaning up balance sheet. Stock price is at attractive level.
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly This North American producer of packaging and tissue products recently beat earnings estimates by 50%. It trades under book value and only 7x earnings -- good value here. Its dividend is strong and growing, backed by a payout ratio under 40% of cash flow. We recommend placing a stop-loss at $8.00, looking to achieve $13.50 -- upside potential over 38%. Yield 5.3% (Analysts’ price target is $13.31)
PAST TOP PICK
(A Top Pick Jul 20/21, Down 40%) Material costs went up, competitive tissue market. Cost pressures on containerboard. Inexpensive valuation, just under book value. A buy at these levels, if your outlook is for the next 3-5 years.
PAST TOP PICK
(A Top Pick Dec 09/21, Down 39%) Input costs rising, delays in materials and labour. Containerboard's been doing OK. Buy at half of book value, and sell at 1.5x. Hold on, still likes. Facing inflation on logistics. Compelling valuation right now, a Buy.
COMMENT
There have been lower volumes and inflationary issues on the tissue side and also on the container board side. With a re-balancing of inventories it should do better. It has a very good valuation with some very good quality assets. Buy for the long term.
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Aug 11/22, Down 17%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CAS has triggered its stop at $8. To remain disciplined, we recommend covering the position at this time.
TOP PICK

They've been hit by a lot of input costs, which may be easing now. It's hard to raise prices on tissue paper and costs have been rising on recycled fibre. Their new container board factory will operate soon. CAS is selling at the low end of its range historically. But be patient until the stock price doubles or even triples.

(Analysts’ price target is $9.83)

HOLD

Likes it, though shares have been down the past year. They fixed their operational issues. Demand remains strong in container board, and they opened a facility in Virginia which could raise margins. They sold their European division, so are more streamlined in operations. Pays around a 4% dividend. Still likes it.

WAIT

It is halfway between the bottom and top of its chart. It shouldn't be overly troubled by a recession but like many other companies would be affected.

HOLD

Huge new facility is coming onstream, and fundamentals in containerboard are more solid than in the very competitive tissue market. Facility over budget, so will take a while to get a return. Focused on debt reduction.